Epigenetic Silencing of miR-203 Upregulates SNAI2 and Contributes to the Invasiveness of Malignant Breast Cancer Cells.
about
MicroRNA aberrations: An emerging field for gallbladder cancer managementMicroRNAs: regulators of cancer metastasis and epithelial-mesenchymal transition (EMT)ΔNp63α and microRNAs: leveraging the epithelial-mesenchymal transitionTackling Cancer Stem Cells via Inhibition of EMT Transcription FactorsNoncoding RNAs in Tumor Epithelial-to-Mesenchymal TransitionKLF5 inhibits angiogenesis in PTEN-deficient prostate cancer by attenuating AKT activation and subsequent HIF1α accumulationRole of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives.miRNAs and cancer: an epigenetics view.Multilayer control of the EMT master regulators.Genome-wide DNA methylome analysis reveals epigenetically dysregulated non-coding RNAs in human breast cancer.Syndecan binding protein (SDCBP) is overexpressed in estrogen receptor negative breast cancers, and is a potential promoter for tumor proliferation.Deciphering the unique microRNA signature in human esophageal adenocarcinomaA Bmi1-miRNAs cross-talk modulates chemotherapy response to 5-fluorouracil in breast cancer cellsMicroRNA regulation and therapeutic targeting of survivin in cancer.Downregulation of microRNA-100 enhances the ICMT-Rac1 signaling and promotes metastasis of hepatocellular carcinoma cells.Genome wide expression profiling of p53 regulated miRNAs in neuroblastomaTargeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease.Small RNAs in metastatic and non-metastatic oral squamous cell carcinoma.Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraitsComparative effects of diet and carcinogen on microRNA expression in the stem cell niche of the mouse colonic cryptCytosolic TMEM88 promotes triple-negative breast cancer by interacting with Dvl.miR-203 Functions as a Tumor Suppressor by Inhibiting Epithelial to Mesenchymal Transition in Ovarian CancerAngiopoietin-like protein 1 suppresses SLUG to inhibit cancer cell motility.Methylation-mediated transcriptional repression of microRNAs during cervical carcinogenesis.Signaling between transforming growth factor β (TGF-β) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasisLong-term exposure of MCF-12A normal human breast epithelial cells to ethanol induces epithelial mesenchymal transition and oncogenic features.microRNA-203 suppresses invasion and epithelial-mesenchymal transition induction via targeting NUAK1 in head and neck cancer.Inferred miRNA activity identifies miRNA-mediated regulatory networks underlying multiple cancers.miR-203 facilitates tumor growth and metastasis by targeting fibroblast growth factor 2 in breast cancerMicroRNA-mediated epigenetic targeting of Survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancer.KLF5 activates microRNA 200 transcription to maintain epithelial characteristics and prevent induced epithelial-mesenchymal transition in epithelial cells.REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3A directly negative interaction of miR-203 and ZEB2 modulates tumor stemness and chemotherapy resistance in nasopharyngeal carcinoma.miR-203 inhibits augmented proliferation and metastasis of hepatocellular carcinoma residual in the promoted regenerating liverEMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness.RUNX2 in mammary gland development and breast cancer.Microenvironmental regulation of cancer metastasis by miRNAs.Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer.Analyzing the differentially expressed genes and pathway cross-talk in aggressive breast cancer.
P2860
Q26768416-1CFE2046-A44D-4395-B460-B9F2A42EB007Q26853284-033D3009-E062-4CFB-B19D-1C5E7B349C84Q28077508-8576F77E-EAB2-46A7-A89F-BB106B1A3C27Q28079863-726756AD-7FBD-4035-92F0-86621CEE8402Q28080346-4573528A-9616-42DD-8D5C-F6DFC36DB89EQ28393007-38E648B2-BBDF-42D1-A380-FD65BF3C70EBQ33559304-5C09A711-2BCF-4DD1-A067-2FEB68688675Q34286618-B7D88440-C695-4586-BFC4-DB466DF3EBAEQ34340552-C5B48549-D019-442F-9487-FDDE591EAC9BQ34465725-FF404DFC-AA9D-47DB-B680-FCD339B0EA03Q34638020-D7F0E687-F90C-469B-8561-B24D194C8332Q34749597-E98CDEC7-4585-40BD-BCE0-5A2BCE45B409Q34988940-0EE6A4EA-8688-4CCB-BB4D-91527C2D3F28Q34991312-69D17753-C50E-4953-99DB-6A393E48CB44Q35067883-A2F727DE-5CD0-41F5-BAFA-03CBBAD56F14Q35169491-1E46920D-BF59-43C3-9B09-998EF8283D03Q35251618-6EDBFCDC-FF2B-42B3-AC07-BC7996955523Q35672177-EE898E23-489F-482F-BCC9-730617F3444BQ35835164-993E17AC-C856-4184-8309-A524E790D27CQ36359569-0F5D771F-5BD5-40DA-B66B-80334873A354Q36413113-9E20B9BA-48B7-4A58-9DFD-91F34E092CDEQ36497625-F3890538-A42E-4794-93E4-D51F3A306808Q36638117-4C4F9091-44B7-4B6B-A300-4AC34EC4433FQ36670003-FFA8999E-CF0E-43EA-A645-C7811494A23BQ36760255-9975CE65-0A8F-45DE-B3AC-F5F8F88E4FA4Q36892620-576CB080-7736-4CE9-884E-24E853C35A33Q36946761-3EB5BFC3-70AD-46A4-8A82-BF650E1C7AE8Q37220598-481BB58F-1EE3-4885-B853-C0C680EDEF02Q37344496-733BBEDA-66E8-4B99-9762-B31C558FEE6FQ37437269-0230C2BC-311F-49F7-B4E1-240AA03E5830Q37469496-35520742-292C-4EC0-A833-5B1BBE4B6C16Q37590737-17FA3BF8-FC05-40E4-9784-DD45C3788036Q37629076-503ECD64-D479-44F5-B9F1-6C5C7E4FEE52Q37687156-9DE8BF96-AA36-49C8-9F29-069D545C98C6Q37735613-73490492-15EF-40B5-9D1A-7F65C4C19D05Q38040369-B5794CD4-AF6B-4A2B-A6B0-DC05C375EFA5Q38061373-76071142-0A39-4B87-84F3-49772C64A114Q38152548-49B31FAA-10B2-4791-A20F-47D28319FF16Q38309242-A374C9FB-75D1-4290-8F66-19E30B4FF197Q38472495-C525E00F-EDDF-4274-9907-A77693134CE4
P2860
Epigenetic Silencing of miR-203 Upregulates SNAI2 and Contributes to the Invasiveness of Malignant Breast Cancer Cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Epigenetic Silencing of miR-20 ...... Malignant Breast Cancer Cells.
@ast
Epigenetic Silencing of miR-20 ...... Malignant Breast Cancer Cells.
@en
type
label
Epigenetic Silencing of miR-20 ...... Malignant Breast Cancer Cells.
@ast
Epigenetic Silencing of miR-20 ...... Malignant Breast Cancer Cells.
@en
prefLabel
Epigenetic Silencing of miR-20 ...... Malignant Breast Cancer Cells.
@ast
Epigenetic Silencing of miR-20 ...... Malignant Breast Cancer Cells.
@en
P2093
P2860
P50
P356
P1433
P1476
Epigenetic Silencing of miR-20 ...... Malignant Breast Cancer Cells.
@en
P2093
P2860
P304
P356
10.1177/1947601911429743
P577
2011-08-01T00:00:00Z